Purple Biotech (PPBT) Operating Leases (2018 - 2025)
Purple Biotech (PPBT) reported Operating Leases of $244000.0 for Q4 2025, up 33.33% year-over-year from $183000.0 in Q4 2024, and up 33.33% on a QoQ basis from $183000.0 in Q4 2024.
Purple Biotech (PPBT) has 8 years of Operating Leases data on file, last reported at $244000.0 in Q4 2025.
- Quarterly Operating Leases rose 33.33% year-over-year to $244000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $244000.0 (up 33.33% YoY) and the FY2025 annual result came in at $244000.0, up 33.33% from the prior year.
- Operating Leases grew to $244000.0 in Q4 2025 per PPBT's latest filing, from $183000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $550000.0 in Q4 2021 and bottomed at $163000.0 in Q4 2023.
- The 5-year median for Operating Leases is $244000.0 (2025), against an average of $292200.0.
- The widest annual swing landed in 2023, when Operating Leases tumbled 49.22%; it then jumped 33.33% in 2025.
- Tracing PPBT's Operating Leases over 5 years: stood at $550000.0 in 2021, then tumbled by 41.64% to $321000.0 in 2022, then slumped by 49.22% to $163000.0 in 2023, then increased by 12.27% to $183000.0 in 2024, then jumped by 33.33% to $244000.0 in 2025.
- Per Business Quant, the three latest PPBT Operating Leases figures stand at $244000.0 (Q4 2025), $183000.0 (Q4 2024), and $163000.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 49,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 121,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 192,000.00 |
| Jun 30, 2023 | 237,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Dec 31, 2022 | 321,000.00 |
| Sep 30, 2022 | 357,000.00 |
| Jun 30, 2022 | 399,000.00 |
| Mar 31, 2022 | 495,000.00 |
| Dec 31, 2021 | 550,000.00 |
| Sep 30, 2021 | 563,000.00 |
| Jun 30, 2021 | 605,000.00 |
| Mar 31, 2021 | 622,000.00 |
| Dec 31, 2020 | 1.05 Mn |
| Jun 30, 2020 | 8,000.00 |
| Dec 31, 2019 | 28,000.00 |
| Jun 30, 2019 | 132,000.00 |
| Dec 31, 2018 | 400,000.00 |